ARK Genomic Revolution ETF
ARKG
Closed
$34.88
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
ARKG was created on 2014-10-31 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 1131.59m in AUM and 33 holdings. ARKG is an actively managed fund that targets companies involved in the genomics industry.
Company
ARK
Asset class
Equity
Inception date
2014
Investment segment
Theme
ISIN
US00214Q3020
Website
Key stats
Open
$35.43
Volume
3.64M
AUM
$1.25B
Prev. close
$35.10
Expense ratio
0.75%
P/E
0.00
$34.84
Day’s Range
$35.60
$24.60
52W Range
$37.30
What’s in the fund
3
Total sectors
Health Care
98.36%
Information Technology
1.34%
Others
0.30%
Returns
Performance
_
Difference
_
ARK Genomic Revolution ETF
Dec
31
Dividends
The last payment date was Dec 31, 2021
Div. per Share
$0.38
Div. Yield
1.09%
Div. Growth YoY
-10.15%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply